Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-11-005239
Filing Date
2011-01-10
Accepted
2011-01-10 17:27:00
Documents
3
Period of Report
2011-01-10

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d6k.htm 6-K 11180
2 PRESS RELEASE DATED JANUARY 10, 2011 dex991.htm EX-99.1 16544
3 GRAPHIC g135889g43j52.jpg GRAPHIC 3107
  Complete submission text file 0001193125-11-005239.txt   33556
Mailing Address 200-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 200-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
TEKMIRA PHARMACEUTICALS CORP (Filer) CIK: 0001447028 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-34949 | Film No.: 11520974
SIC: 2834 Pharmaceutical Preparations